Materiały źródłowe

• #1 Pyoderma Gangrenosum – Dermatologic Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/dermatologic-disorders/hypersensitivity-and-reactive-skin-disorders/pyoderma-gangrenosum

  Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. […] Treatment includes wound care and, based on severity, anti-inflammatory medications or immunosuppressants. […] Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. […] Wound healing can be promoted with moisture-retaining occlusive dressings for less exudative plaques and absorptive dressings for highly exudative plaques. […] Optimize wound care and avoid surgical debridement. […] Use potent topical corticosteroids or tacrolimus to treat early lesions and use systemic corticosteroids, tumor necrosis factor (TNF)-alpha inhibitors, or other anti-inflammatories or immunosuppressants to treat more severe manifestations.

• #2 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  Pyoderma gangrenosum (PG) is a reactive non-infectious inflammatory dermatosis falling under the spectrum of the neutrophilic dermatoses. Treatment of PG remains largely anecdotal, with no national or international guidelines, and is selected according to severity and rate of progression. Despite being a well-recognised condition, there is often a failure to make an early diagnosis of PG. This diagnosis should be actively considered when assessing ulcers, as prompt treatment may avoid the complications of prolonged systemic therapy, delayed wound healing and scarring. […] First-line treatment is aimed at optimising local wound care, particularly important in cases of PG arising on the leg, where wound healing can be delayed by vascular disease. Supportive therapy with appropriate dressings, compression (if arterial insufficiency has been excluded) and adequate analgesia are all essential to optimise healing. Potent topical corticosteroids and tacrolimus ointment applied to the ulcer surface are useful and intralesional injections of corticosteroid into the erythematous active border may be considered.

• #3 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Pyoderma gangrenosum (PG) is a rare neutrophilic ulcerative dermatosis that poses a high burden of morbidity due to underdiagnosis, resistance to therapy, and limited therapeutic options. […] Optimization of wound care strategies and multimodal anti-inflammatory approaches are necessary to mitigate multiple converging pathways of inflammation leading to delayed healing, which is further complicated by additional factors such as pathergy. […] Wound management includes gentle cleansing without sharp debridement, limited topical antibacterial use, and maintenance of a moist environment to promote epithelial migration. […] Dressings should aim to target the specific PG wound type, depending on the depth and exudative nature of the wound, as well as local secondary factors. […] The importance of compression therapy to decrease edema and overgranulation fits within this treatment paradigm.

• #4 Pyoderma Gangrenosum: Causes, Symptoms & Treatments

  https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg

  Pyoderma gangrenosum is a skin condition linked to certain autoimmune diseases or an earlier skin injury. […] Medications and other treatment options can relieve your symptoms. […] Early diagnosis and treatment are important in preventing scars. […] Trauma, including cuts, punctures and scrapes, can worsen your symptoms. Be careful to avoid any trauma that can cause more ulcers. […] It’s also important to keep your wounds clean to prevent infection. […] If you have a prescribed topical medication, wash your wound with clean running water and soap. Apply the medication to your wound, and then cover it with a nonadhesive bandage. […] For more severe ulcers, your healthcare provider may recommend covering them in a hydrocolloid bandage (dressing). […] Pyoderma gangrenosum is difficult to treat. Even with proper treatment, it may take weeks or even months to heal. […] If you have pyoderma gangrenosum, it’s important to discuss your diagnosis with any healthcare provider who’s considering a procedure that may damage your skin, such as surgery. […] They must consider if the procedure’s benefits outweigh the risks of triggering pyoderma gangrenosum.

• #5 Pyoderma gangrenosum – Autoimmune Association

  https://autoimmune.org/disease-information/pyoderma-gangrenosum/

  Pyoderma gangrenosum is an uncommon, ulcerative cutaneous condition of uncertain etiology (cause). […] The prognosis of pyoderma gangrenosum is generally good; however, the disease may recur, and residual scarring is common. Pain is a common complaint of patients and may require narcotics. […] Treatment involves wound care and the use of anti-inflammatory agents, including antibiotics, corticosteroids, immunosuppressants, and biologics.

• #6 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Once inflammation is maintained by local or systemic suppressive therapies, the importance of site-specific wound care is of highest consideration. […] Gentle mechanical debridement, considering risk of pathergy, an exaggerated skin injury occurring after minor trauma, and inhibition of critical colonization are essential throughout the phases of wound healing. […] Topical antibacterial use in cases of critical colonization and maintenance of an appropriately moist environment are necessary to promote epithelial migration with any acute or chronic cutaneous ulceration. […] The tissue debridement, control of infection/inflammation, moisture balance, and edge effect (TIME) principle, a guide for local wound care: the TIME. […] Overall, dressings should be nonadherent to the wound bed and removed easily to minimize trauma and subsequent pain, as well as pathergy.

• #7 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #8 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Patients with PG must be managed by dermatologists with experience treating internal medicine patients, or in cooperation with an internist. Patients must be informed of the expected healing time of the ulcers, the importance of topical care, and the careful monitoring of the efficacy and side effects of the drugs used. […] Nurses and other health professionals must work in close contact with the physicians. It is important to emphasize to the patient the fact that the ulcerations, even the most dramatic ones, will heal, usually only leaving a slightly atrophic, depressed scar. In patients with recurrent PG, maintenance therapy with low-dose steroids and/or immunosuppressives will help prevent new lesions.

• #9 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #10 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #11 Pyoderma Gangrenosum: Symptoms, Causes, and Treatment Options – The Kingsley Clinic

  https://thekingsleyclinic.com/resources/pyoderma-gangrenosum-symptoms-causes-and-treatment-options/

  If you notice signs of infection, such as increased redness, swelling, or pus, seek medical attention immediately. […] Living with Pyoderma gangrenosum can be challenging, but several strategies can help improve your quality of life: Follow your treatment plan closely and attend all follow-up appointments to monitor your condition. Practice diligent wound care to prevent infections and promote healing. Manage stress, as it can trigger flare-ups of autoimmune conditions. Stay connected with a support group or counselor to help cope with the emotional impact of living with a chronic condition. Consider telemedicine for regular check-ins with your healthcare provider, offering convenience and flexibility. […] Early intervention with medications and proper wound care can help manage symptoms and prevent complications.

• #12

  https://link.springer.com/article/10.1007/s40265-023-01931-3

  When PG occurs on the lower legs, compression bandages should be applied to support anti-inflammatory activity by reducing oedema. […] Pain remains an important aspect to take into consideration when addressing the severity of PG. […] The addition of systemic treatment should be considered if progress is lacking after 24 weeks of therapy. […] In general, topical therapy for PG is used as an adjuvant to systemic therapy and is usually applied to the ulcer itself and/or ulcer edges. […] It is always difficult to determine when systemic therapy should be stopped. […] With control of the inflammation, the pain should decrease and the livid border around the wound should recede. […] In the future, we need to deepen our understanding of the pathophysiology of this disease, search for specific markers to aid in the enrolment of patients in clinical studies and possibly to distinguish PG from other ulcerative skin diseases, and ultimately develop targeted therapies that can feasible be studied in RCTs.

• #13 Pyoderma Gangrenosum Causes, Treatments, & Misdiagnosis

  https://www.epiphanydermatology.com/medical-dermatology/pyoderma-gangrenosum-treatment/

  Pyoderma gangrenosum treatment is extremely different from treating the illnesses it mimics. Typically, treating PG requires a high-dose systemic corticosteroid or immunomodulating medications such as cyclosporine or the biologics instead of debridement, which makes the issue worse. […] Once a PG diagnosis is confirmed, with a combination of histopathology from a biopsy and the clinical signs recognized by the clinician, patients often begin a combination of topical and systemic therapies. Most patients need systemic immunosuppressant therapy (such as prednisone) to induce remission. Antibiotics such as tetracyclines may also be used in conjunction for their anti-inflammatory effects. […] Undiagnosed cases of pyoderma gangrenosum can be life-altering for the patient. These chronic wounds produce intense pain, odor, and discomfort. Plus, they often affect a patients emotional well-being, as wound care can be both depressing and isolating.

• #14 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Pyoderma gangrenosum (PG) is a rare neutrophilic ulcerative dermatosis that poses a high burden of morbidity due to underdiagnosis, resistance to therapy, and limited therapeutic options. […] Optimization of wound care strategies and multimodal anti-inflammatory approaches are necessary to mitigate multiple converging pathways of inflammation leading to delayed healing, which is further complicated by additional factors such as pathergy. […] Wound management includes gentle cleansing without sharp debridement, limited topical antibacterial use, and maintenance of a moist environment to promote epithelial migration. […] Dressings should aim to target the specific PG wound type, depending on the depth and exudative nature of the wound, as well as local secondary factors. […] The importance of compression therapy to decrease edema and overgranulation fits within this treatment paradigm.

• #15 Pyoderma Gangrenosum – Dermatologic Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/dermatologic-disorders/hypersensitivity-and-reactive-skin-disorders/pyoderma-gangrenosum

  Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. […] Treatment includes wound care and, based on severity, anti-inflammatory medications or immunosuppressants. […] Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. […] Wound healing can be promoted with moisture-retaining occlusive dressings for less exudative plaques and absorptive dressings for highly exudative plaques. […] Optimize wound care and avoid surgical debridement. […] Use potent topical corticosteroids or tacrolimus to treat early lesions and use systemic corticosteroids, tumor necrosis factor (TNF)-alpha inhibitors, or other anti-inflammatories or immunosuppressants to treat more severe manifestations.

• #16 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Pyoderma gangrenosum (PG) is a rare neutrophilic ulcerative dermatosis that poses a high burden of morbidity due to underdiagnosis, resistance to therapy, and limited therapeutic options. […] Optimization of wound care strategies and multimodal anti-inflammatory approaches are necessary to mitigate multiple converging pathways of inflammation leading to delayed healing, which is further complicated by additional factors such as pathergy. […] Wound management includes gentle cleansing without sharp debridement, limited topical antibacterial use, and maintenance of a moist environment to promote epithelial migration. […] Dressings should aim to target the specific PG wound type, depending on the depth and exudative nature of the wound, as well as local secondary factors. […] The importance of compression therapy to decrease edema and overgranulation fits within this treatment paradigm.

• #17 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Compression therapy first reduces inflammation and fluid accumulation, which would otherwise impede wound healing. […] Compression therapy has been found to be an effective treatment for PG without major adverse effects. […] A multimodal approach to effective PG treatment has been demonstrated in the literature. […] The wound care process in PG always involves gentle cleansing, topical antibacterial use in cases of suspected colonization or infection, as well as maintenance of appropriate fluid balance. […] Numerous dressings can be used to target the specific wound type in PG, including superficial wounds, eschar, exudative wounds, granulating wounds, and colonized wounds.

• #18 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Pyoderma gangrenosum (PG) is a rare neutrophilic ulcerative dermatosis that poses a high burden of morbidity due to underdiagnosis, resistance to therapy, and limited therapeutic options. […] Optimization of wound care strategies and multimodal anti-inflammatory approaches are necessary to mitigate multiple converging pathways of inflammation leading to delayed healing, which is further complicated by additional factors such as pathergy. […] Wound management includes gentle cleansing without sharp debridement, limited topical antibacterial use, and maintenance of a moist environment to promote epithelial migration. […] Dressings should aim to target the specific PG wound type, depending on the depth and exudative nature of the wound, as well as local secondary factors. […] The importance of compression therapy to decrease edema and overgranulation fits within this treatment paradigm.

• #19 Pyoderma Gangrenosum – Dermatologic Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/dermatologic-disorders/hypersensitivity-and-reactive-skin-disorders/pyoderma-gangrenosum

  Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. […] Treatment includes wound care and, based on severity, anti-inflammatory medications or immunosuppressants. […] Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. […] Wound healing can be promoted with moisture-retaining occlusive dressings for less exudative plaques and absorptive dressings for highly exudative plaques. […] Optimize wound care and avoid surgical debridement. […] Use potent topical corticosteroids or tacrolimus to treat early lesions and use systemic corticosteroids, tumor necrosis factor (TNF)-alpha inhibitors, or other anti-inflammatories or immunosuppressants to treat more severe manifestations.

• #20 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Once inflammation is maintained by local or systemic suppressive therapies, the importance of site-specific wound care is of highest consideration. […] Gentle mechanical debridement, considering risk of pathergy, an exaggerated skin injury occurring after minor trauma, and inhibition of critical colonization are essential throughout the phases of wound healing. […] Topical antibacterial use in cases of critical colonization and maintenance of an appropriately moist environment are necessary to promote epithelial migration with any acute or chronic cutaneous ulceration. […] The tissue debridement, control of infection/inflammation, moisture balance, and edge effect (TIME) principle, a guide for local wound care: the TIME. […] Overall, dressings should be nonadherent to the wound bed and removed easily to minimize trauma and subsequent pain, as well as pathergy.

• #21 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Wound management and topical care are important, but a systemic antiinflammatory / immunosuppressive drug is the main focus of PG management. […] Topical wound care requires experienced health professionals. Treatments must reduce pain and avoid superinfection. It is also important to minimize any physical trauma, including physical wound debridement, as pathergy is a cause of initiation or aggravation of PG lesions. […] Antiseptic solutions must be used for cleansing. Nonadhesive dressings should be applied over the lesions and held in place with elasticized bandages. Hydrocolloid dressings are useful. […] Systemic antiimmflamatory/immunosuppressive therapy should be intiated promptly after diagnosis confirmation. As mentioned in treatment options, corticosteroids are the treatment of choice for inital therapy to suppress the inflammatory process. After an initial suppression period of at least 6 weeks (depending on the size and number of lesions), a steroid-sparing agent is typically added and steroid/steroid-sparing therapies are consolidated so that corticosteroids can be weaned and the patient can be maintained on a steroid-sparing agent.

• #22 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #23 Pyoderma Gangrenosum – Dermatologic Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/dermatologic-disorders/hypersensitivity-and-reactive-skin-disorders/pyoderma-gangrenosum

  Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. […] Treatment includes wound care and, based on severity, anti-inflammatory medications or immunosuppressants. […] Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. […] Wound healing can be promoted with moisture-retaining occlusive dressings for less exudative plaques and absorptive dressings for highly exudative plaques. […] Optimize wound care and avoid surgical debridement. […] Use potent topical corticosteroids or tacrolimus to treat early lesions and use systemic corticosteroids, tumor necrosis factor (TNF)-alpha inhibitors, or other anti-inflammatories or immunosuppressants to treat more severe manifestations.

• #24 Pyoderma Gangrenosum – Dermatologic Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/dermatologic-disorders/hypersensitivity-and-reactive-skin-disorders/pyoderma-gangrenosum

  Pyoderma gangrenosum is a chronic, neutrophilic, progressive skin necrosis of unknown etiology often associated with systemic illness and sometimes skin injury. […] Treatment includes wound care and, based on severity, anti-inflammatory medications or immunosuppressants. […] Diagnosis of pyoderma gangrenosum is clinical and is a diagnosis of exclusion after other causes of ulceration have been ruled out. […] Wound healing can be promoted with moisture-retaining occlusive dressings for less exudative plaques and absorptive dressings for highly exudative plaques. […] Optimize wound care and avoid surgical debridement. […] Use potent topical corticosteroids or tacrolimus to treat early lesions and use systemic corticosteroids, tumor necrosis factor (TNF)-alpha inhibitors, or other anti-inflammatories or immunosuppressants to treat more severe manifestations.

• #25 Pyoderma gangrenosum: a review of the clinical, mechanistic and therapeutic landscape :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-30-number-1/pyoderma-gangrenosum-review-clinical-mechanistic-and-therapeutic-landscape

  Pyoderma gangrenosum (PG) is a neutrophilic dermatosis that is uncommon and can sometimes be associated with systemic diseases. […] Current management involves optimal wound care and topical or systemic steroids or steroid sparing agents. Certain biological agents, including IL23 and IL17 antagonists, as well as JAK-STAT inhibitors, however, may hold promise in the rapid treatment of this condition. […] A combination of local and systemic treatments, along with regular wound care, has been found to confer the highest likelihood of adequate ulcer healing. […] The main goals are to protect the ulcers from experiencing further physical trauma and fostering a microenvironment that enables wound healing. […] Active ulcers will usually produce large amounts of exudate due to high neutrophil activity, which leaves the surrounding normal skin at risk of maceration and infection.

• #26 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Wound management and topical care are important, but a systemic antiinflammatory / immunosuppressive drug is the main focus of PG management. […] Topical wound care requires experienced health professionals. Treatments must reduce pain and avoid superinfection. It is also important to minimize any physical trauma, including physical wound debridement, as pathergy is a cause of initiation or aggravation of PG lesions. […] Antiseptic solutions must be used for cleansing. Nonadhesive dressings should be applied over the lesions and held in place with elasticized bandages. Hydrocolloid dressings are useful. […] Systemic antiimmflamatory/immunosuppressive therapy should be intiated promptly after diagnosis confirmation. As mentioned in treatment options, corticosteroids are the treatment of choice for inital therapy to suppress the inflammatory process. After an initial suppression period of at least 6 weeks (depending on the size and number of lesions), a steroid-sparing agent is typically added and steroid/steroid-sparing therapies are consolidated so that corticosteroids can be weaned and the patient can be maintained on a steroid-sparing agent.

• #27 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #28 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Wound management and topical care are important, but a systemic antiinflammatory / immunosuppressive drug is the main focus of PG management. […] Topical wound care requires experienced health professionals. Treatments must reduce pain and avoid superinfection. It is also important to minimize any physical trauma, including physical wound debridement, as pathergy is a cause of initiation or aggravation of PG lesions. […] Antiseptic solutions must be used for cleansing. Nonadhesive dressings should be applied over the lesions and held in place with elasticized bandages. Hydrocolloid dressings are useful. […] Systemic antiimmflamatory/immunosuppressive therapy should be intiated promptly after diagnosis confirmation. As mentioned in treatment options, corticosteroids are the treatment of choice for inital therapy to suppress the inflammatory process. After an initial suppression period of at least 6 weeks (depending on the size and number of lesions), a steroid-sparing agent is typically added and steroid/steroid-sparing therapies are consolidated so that corticosteroids can be weaned and the patient can be maintained on a steroid-sparing agent.

• #29 Pyoderma gangrenosum | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/pyoderma-gangrenosum

  Pyoderma gangrenosum (pie-o-DUR-muh gang-ruh-NO-sum) is a rare condition that causes large, painful sores on the skin. The condition usually clears up with treatment. But the sores often leave scars and can show up in new spots. […] Treatment of pyoderma gangrenosum is aimed at reducing swelling, controlling pain and helping skin sores heal. Medicines are the most common treatment. Treatment also might involve wound care and surgery. Your treatment depends on your health, how many sores you have, how deep they are and how fast they’re growing. […] In addition to applying medicine to your wounds, a healthcare professional may cover them with a moist nonstick dressing and, perhaps, an elasticized wrap. You may be asked to keep the affected area raised. Follow instructions you receive for wound care.

• #30 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Pyoderma gangrenosum (PG) is a rare neutrophilic ulcerative dermatosis that poses a high burden of morbidity due to underdiagnosis, resistance to therapy, and limited therapeutic options. […] Optimization of wound care strategies and multimodal anti-inflammatory approaches are necessary to mitigate multiple converging pathways of inflammation leading to delayed healing, which is further complicated by additional factors such as pathergy. […] Wound management includes gentle cleansing without sharp debridement, limited topical antibacterial use, and maintenance of a moist environment to promote epithelial migration. […] Dressings should aim to target the specific PG wound type, depending on the depth and exudative nature of the wound, as well as local secondary factors. […] The importance of compression therapy to decrease edema and overgranulation fits within this treatment paradigm.

• #31 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Compression therapy first reduces inflammation and fluid accumulation, which would otherwise impede wound healing. […] Compression therapy has been found to be an effective treatment for PG without major adverse effects. […] A multimodal approach to effective PG treatment has been demonstrated in the literature. […] The wound care process in PG always involves gentle cleansing, topical antibacterial use in cases of suspected colonization or infection, as well as maintenance of appropriate fluid balance. […] Numerous dressings can be used to target the specific wound type in PG, including superficial wounds, eschar, exudative wounds, granulating wounds, and colonized wounds.

• #32 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum on the legs needs compression therapy alongside the medical management. […] The powerful anti-inflammatory effects of compression therapy can get missed whilst the doctors focus on establishing the correct medication. […] Whilst PG is not caused by venous hypertension, any wound on the leg heals faster with compression therapy.

• #33 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum is often difficult to treat and may take some time to heal, especially if the lesions are on the lower leg. Treatment requires the following important interventions. […] Management of pain is essential this condition can be extremely painful and the patient will need strong analgesia initially often suggested by the Dermatologist. It is important to have treatment for neuropathic pain and anti-neuropathic medication will be required if compression is to be tolerated. Pain will reduce if the inflammatory condition is under control with the medication. […] Compression is an essential part of the treatment if you have PG on your legs or feet and this important fact is often missed. Medical management may not be enough on its own to control this condition or any associated swelling. Even if the leg is not very swollen the compression bandage or sock will reduce the level of exudate and make the wounds less wet. You may want to start with mild compression, but increase the level of compression as soon as you can so the limb can benefit from the anti-inflammatory properties of the compression therapy.

• #34 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum is often difficult to treat and may take some time to heal, especially if the lesions are on the lower leg. Treatment requires the following important interventions. […] Management of pain is essential this condition can be extremely painful and the patient will need strong analgesia initially often suggested by the Dermatologist. It is important to have treatment for neuropathic pain and anti-neuropathic medication will be required if compression is to be tolerated. Pain will reduce if the inflammatory condition is under control with the medication. […] Compression is an essential part of the treatment if you have PG on your legs or feet and this important fact is often missed. Medical management may not be enough on its own to control this condition or any associated swelling. Even if the leg is not very swollen the compression bandage or sock will reduce the level of exudate and make the wounds less wet. You may want to start with mild compression, but increase the level of compression as soon as you can so the limb can benefit from the anti-inflammatory properties of the compression therapy.

• #35 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  Pyoderma gangrenosum (PG) is a reactive non-infectious inflammatory dermatosis falling under the spectrum of the neutrophilic dermatoses. Treatment of PG remains largely anecdotal, with no national or international guidelines, and is selected according to severity and rate of progression. Despite being a well-recognised condition, there is often a failure to make an early diagnosis of PG. This diagnosis should be actively considered when assessing ulcers, as prompt treatment may avoid the complications of prolonged systemic therapy, delayed wound healing and scarring. […] First-line treatment is aimed at optimising local wound care, particularly important in cases of PG arising on the leg, where wound healing can be delayed by vascular disease. Supportive therapy with appropriate dressings, compression (if arterial insufficiency has been excluded) and adequate analgesia are all essential to optimise healing. Potent topical corticosteroids and tacrolimus ointment applied to the ulcer surface are useful and intralesional injections of corticosteroid into the erythematous active border may be considered.

• #36 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum is often difficult to treat and may take some time to heal, especially if the lesions are on the lower leg. Treatment requires the following important interventions. […] Management of pain is essential this condition can be extremely painful and the patient will need strong analgesia initially often suggested by the Dermatologist. It is important to have treatment for neuropathic pain and anti-neuropathic medication will be required if compression is to be tolerated. Pain will reduce if the inflammatory condition is under control with the medication. […] Compression is an essential part of the treatment if you have PG on your legs or feet and this important fact is often missed. Medical management may not be enough on its own to control this condition or any associated swelling. Even if the leg is not very swollen the compression bandage or sock will reduce the level of exudate and make the wounds less wet. You may want to start with mild compression, but increase the level of compression as soon as you can so the limb can benefit from the anti-inflammatory properties of the compression therapy.

• #37 Pyoderma gangrenosum: a review of the clinical, mechanistic and therapeutic landscape :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-30-number-1/pyoderma-gangrenosum-review-clinical-mechanistic-and-therapeutic-landscape

  If this occurs, antimicrobial dressings including those containing silver, will reduce the bacterial load due to its ability to damage the bacterial cell wall and membrane. […] PG ulcers on the lower legs may lead to the development of oedema secondary to ongoing inflammation. In such cases, gentle compression stockings or wraps, along with leg elevation, may reduce the oedema.

• #38 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Systemic therapy is required in patients with all but superficial lesions. Topical agents also do not address systemic disease and as the disease progresses a combination of topical and systemic agents may be required. […] Surgery is not generally recommended due to the risk of pathergy; as a result the ulcers could potentially worsen following surgery. However, there are a few reports in the literature of success following surgical intervention. […] Pain associated with PG can be distressing for the patient. Patients report the pain as stabbing in nature. There are reports of severe pain leading to amputation of the affected limb. The source of pain associated with PG is multifactorial and is attributed to the inflammatory process in the dermis and subsequent ulceration. Pain levels should be monitored and as the ulcer improves pain levels should decrease.

• #39 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Systemic therapy is required in patients with all but superficial lesions. Topical agents also do not address systemic disease and as the disease progresses a combination of topical and systemic agents may be required. […] Surgery is not generally recommended due to the risk of pathergy; as a result the ulcers could potentially worsen following surgery. However, there are a few reports in the literature of success following surgical intervention. […] Pain associated with PG can be distressing for the patient. Patients report the pain as stabbing in nature. There are reports of severe pain leading to amputation of the affected limb. The source of pain associated with PG is multifactorial and is attributed to the inflammatory process in the dermis and subsequent ulceration. Pain levels should be monitored and as the ulcer improves pain levels should decrease.

• #40 Pyoderma Gangrenosum Treatment: Top Management Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/pyoderma-gangrenosum-treatment-top-management-strategies/

  Pyoderma gangrenosum is a rare but serious neutrophilic dermatosis that can be tough to manage. […] Comprehensive wound care, including proper cleaning and dressing, significantly aids in healing and therapy for classic pyoderma. […] Specialized wound care is vital in managing pyoderma gangrenosum. This includes regular cleaning, applying appropriate dressings, and monitoring for infections. […] Pain management is necessary for patients with pyoderma gangrenosum. Dressing changes can be particularly painful. Doctors often recommend pain relief medications before changing dressings. […] Regular monitoring of the wound is essential. Doctors need to check for signs of infection or other complications. Patients may need frequent visits to their healthcare provider to ensure proper healing.

• #41 Pyoderma gangrenosum – Autoimmune Association

  https://autoimmune.org/disease-information/pyoderma-gangrenosum/

  Pyoderma gangrenosum is an uncommon, ulcerative cutaneous condition of uncertain etiology (cause). […] The prognosis of pyoderma gangrenosum is generally good; however, the disease may recur, and residual scarring is common. Pain is a common complaint of patients and may require narcotics. […] Treatment involves wound care and the use of anti-inflammatory agents, including antibiotics, corticosteroids, immunosuppressants, and biologics.

• #42 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum is often difficult to treat and may take some time to heal, especially if the lesions are on the lower leg. Treatment requires the following important interventions. […] Management of pain is essential this condition can be extremely painful and the patient will need strong analgesia initially often suggested by the Dermatologist. It is important to have treatment for neuropathic pain and anti-neuropathic medication will be required if compression is to be tolerated. Pain will reduce if the inflammatory condition is under control with the medication. […] Compression is an essential part of the treatment if you have PG on your legs or feet and this important fact is often missed. Medical management may not be enough on its own to control this condition or any associated swelling. Even if the leg is not very swollen the compression bandage or sock will reduce the level of exudate and make the wounds less wet. You may want to start with mild compression, but increase the level of compression as soon as you can so the limb can benefit from the anti-inflammatory properties of the compression therapy.

• #43 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum is often difficult to treat and may take some time to heal, especially if the lesions are on the lower leg. Treatment requires the following important interventions. […] Management of pain is essential this condition can be extremely painful and the patient will need strong analgesia initially often suggested by the Dermatologist. It is important to have treatment for neuropathic pain and anti-neuropathic medication will be required if compression is to be tolerated. Pain will reduce if the inflammatory condition is under control with the medication. […] Compression is an essential part of the treatment if you have PG on your legs or feet and this important fact is often missed. Medical management may not be enough on its own to control this condition or any associated swelling. Even if the leg is not very swollen the compression bandage or sock will reduce the level of exudate and make the wounds less wet. You may want to start with mild compression, but increase the level of compression as soon as you can so the limb can benefit from the anti-inflammatory properties of the compression therapy.

• #44 Pyoderma Gangrenosum on the Lower Extremity | Consultant360

  https://www.consultant360.com/photoclinic/pyoderma-gangrenosum-lower-extremity

  A 53-year-old woman presented for a dermatology consult for a spreading ulcer on the lateral left calf. […] Given the pertinent history and physical examination, the condition was diagnosed as pyoderma gangrenosum and was treated with 5 g topical clobetasol 0.05% ointment twice daily under nonadherent dressings. Her pain improved significantly after a single day of treatment. After 3 weeks of treatment, the lesion improved significantly. […] Treatment of pyoderma gangrenosum depends on severity. Stable or slowly growing lesions can be treated with compresses with occlusive dressing as pyoderma gangrenosum can spontaneously regress. Potent topical corticosteroids, topical dapsone, or topical tacrolimus can be considered for more persistent lesions. Rapid progression, extensive disease, or facial involvement may necessitate the use of systemic corticosteroids, cyclosporine, or infliximab. […] First-line treatments include gentle wound care and potent topical corticosteroids with a taper as the lesion improves. When in doubt, consider consulting a dermatologist.

• #45 Pyoderma Gangrenosum Treatment & Management: Approach Considerations, Medical Care, Surgical Care

  https://emedicine.medscape.com/article/1123821-treatment

  No specific therapy is uniformly effective for patients with pyoderma gangrenosum. Therapy for pyoderma gangrenosum involves the use of anti-inflammatory agents, including antibiotics, corticosteroids, immunosuppressive agents, and biologic agents. Although surgical management should generally be avoided if possible, it is sometimes warranted. In patients with an associated underlying disease, effective therapy for the associated condition may be linked to a control of the cutaneous process as well. […] Care of patients with pyoderma gangrenosum is often referred from general dermatologists to tertiary centers where such patients are seen more frequently. […] Patients with pyoderma gangrenosum should receive follow-up care on a regular basis to monitor drug therapy and to measure the size of the lesion or lesions. Multiple methods of wound care are available.

• #46 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #47 Pyoderma Gangrenosum (PG) | OHSU

  https://www.ohsu.edu/dermatology/pyoderma-gangrenosum-pg

  Immunosuppressive medications (topical or systemic) are considered first-line treatments. These include topical corticosteroids (e.g. clobetasol), intralesional corticosteroids (e.g. triamcinolone) or systemic corticosteroids (e.g. prednisone). Other options include topical calcineurin inhibitors (e.g. tacrolimus) or cyclosporine. The presence of associated comorbidities should be considered when selecting medications for maintenance therapy such as biologics (e.g. infliximab in patients with PG and inflammatory bowel disease). Your provider will discuss what options may work best for you. […] We utilize this multidisciplinary care approach in our treatment and research of pyoderma gangrenosum (PG). […] Our dermatologists frequently work with rheumatologists due to the inflammatory nature of PG which can manifest in inflammation of the joints.

• #48 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #49 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #50 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #51 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #52 Pyoderma Gangrenosum Causes, Treatments, & Misdiagnosis

  https://www.epiphanydermatology.com/medical-dermatology/pyoderma-gangrenosum-treatment/

  Pyoderma gangrenosum treatment is extremely different from treating the illnesses it mimics. Typically, treating PG requires a high-dose systemic corticosteroid or immunomodulating medications such as cyclosporine or the biologics instead of debridement, which makes the issue worse. […] Once a PG diagnosis is confirmed, with a combination of histopathology from a biopsy and the clinical signs recognized by the clinician, patients often begin a combination of topical and systemic therapies. Most patients need systemic immunosuppressant therapy (such as prednisone) to induce remission. Antibiotics such as tetracyclines may also be used in conjunction for their anti-inflammatory effects. […] Undiagnosed cases of pyoderma gangrenosum can be life-altering for the patient. These chronic wounds produce intense pain, odor, and discomfort. Plus, they often affect a patients emotional well-being, as wound care can be both depressing and isolating.

• #53 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Patients with PG must be managed by dermatologists with experience treating internal medicine patients, or in cooperation with an internist. Patients must be informed of the expected healing time of the ulcers, the importance of topical care, and the careful monitoring of the efficacy and side effects of the drugs used. […] Nurses and other health professionals must work in close contact with the physicians. It is important to emphasize to the patient the fact that the ulcerations, even the most dramatic ones, will heal, usually only leaving a slightly atrophic, depressed scar. In patients with recurrent PG, maintenance therapy with low-dose steroids and/or immunosuppressives will help prevent new lesions.

• #54 Pyoderma Gangrenosum: Causes, Symptoms & Treatments

  https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg

  Pyoderma gangrenosum is a skin condition linked to certain autoimmune diseases or an earlier skin injury. […] Medications and other treatment options can relieve your symptoms. […] Early diagnosis and treatment are important in preventing scars. […] Trauma, including cuts, punctures and scrapes, can worsen your symptoms. Be careful to avoid any trauma that can cause more ulcers. […] It’s also important to keep your wounds clean to prevent infection. […] If you have a prescribed topical medication, wash your wound with clean running water and soap. Apply the medication to your wound, and then cover it with a nonadhesive bandage. […] For more severe ulcers, your healthcare provider may recommend covering them in a hydrocolloid bandage (dressing). […] Pyoderma gangrenosum is difficult to treat. Even with proper treatment, it may take weeks or even months to heal. […] If you have pyoderma gangrenosum, it’s important to discuss your diagnosis with any healthcare provider who’s considering a procedure that may damage your skin, such as surgery. […] They must consider if the procedure’s benefits outweigh the risks of triggering pyoderma gangrenosum.

• #55 Pyoderma Gangrenosum: Causes, Symptoms & Treatments

  https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg

  Pyoderma gangrenosum is a skin condition linked to certain autoimmune diseases or an earlier skin injury. […] Medications and other treatment options can relieve your symptoms. […] Early diagnosis and treatment are important in preventing scars. […] Trauma, including cuts, punctures and scrapes, can worsen your symptoms. Be careful to avoid any trauma that can cause more ulcers. […] It’s also important to keep your wounds clean to prevent infection. […] If you have a prescribed topical medication, wash your wound with clean running water and soap. Apply the medication to your wound, and then cover it with a nonadhesive bandage. […] For more severe ulcers, your healthcare provider may recommend covering them in a hydrocolloid bandage (dressing). […] Pyoderma gangrenosum is difficult to treat. Even with proper treatment, it may take weeks or even months to heal. […] If you have pyoderma gangrenosum, it’s important to discuss your diagnosis with any healthcare provider who’s considering a procedure that may damage your skin, such as surgery. […] They must consider if the procedure’s benefits outweigh the risks of triggering pyoderma gangrenosum.

• #56 Pyoderma Gangrenosum: Symptoms, Causes, and Treatment Options – The Kingsley Clinic

  https://thekingsleyclinic.com/resources/pyoderma-gangrenosum-symptoms-causes-and-treatment-options/

  If you notice signs of infection, such as increased redness, swelling, or pus, seek medical attention immediately. […] Living with Pyoderma gangrenosum can be challenging, but several strategies can help improve your quality of life: Follow your treatment plan closely and attend all follow-up appointments to monitor your condition. Practice diligent wound care to prevent infections and promote healing. Manage stress, as it can trigger flare-ups of autoimmune conditions. Stay connected with a support group or counselor to help cope with the emotional impact of living with a chronic condition. Consider telemedicine for regular check-ins with your healthcare provider, offering convenience and flexibility. […] Early intervention with medications and proper wound care can help manage symptoms and prevent complications.

• #57 Pyoderma gangrenosum – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/pyoderma-gangrenosum/

  Pyoderma gangrenosum ulcers can develop quickly. They usually clear up with treatment, but scarring and recurrences are common. […] Treatment of pyoderma gangrenosum is aimed at reducing inflammation, controlling pain, promoting wound healing and controlling any underlying disease. Your treatment will depend on several factors, including your health and the number, size, depth and growth rate of your skin ulcers. […] In addition to applying medicine directly to your wounds, your doctor or wound care specialist will cover them with a nonadherent, moist (not wet or dry) dressing and, perhaps, an elasticized wrap. You may be asked to keep the affected area elevated. […] Follow your doctor’s instructions regarding wound care. This is especially important because many of the oral medications prescribed for pyoderma gangrenosum suppress your immune system, which increases your risk of infection.

• #58 Pyoderma Gangrenosum Causes, Treatments, & Misdiagnosis

  https://www.epiphanydermatology.com/medical-dermatology/pyoderma-gangrenosum-treatment/

  However, a correct diagnosis can drastically reduce the physical, psychological, and social effects of PG. Once treatment is initiated, PG ulcers can begin to heal in days, especially decreasing the pain, and the lesions may shrink over weeks to months, leaving a star-like scar. […] It may, unfortunately, return in the same and other sites with the flare of a systemic disorder or trauma. While misdiagnosis can be devastating, an accurate diagnosis and treatment of pyoderma gangrenosum plan can help patients resume a normal life. […] If you or someone you care about has a non-healing wound, talk to a dermatologist about the options and the possibility of pyoderma gangrenosum. The sooner a proper diagnosis is reached, the better and more quickly healing can occur.

• #59 Pyoderma Gangrenosum Causes, Treatments, & Misdiagnosis

  https://www.epiphanydermatology.com/medical-dermatology/pyoderma-gangrenosum-treatment/

  Pyoderma gangrenosum treatment is extremely different from treating the illnesses it mimics. Typically, treating PG requires a high-dose systemic corticosteroid or immunomodulating medications such as cyclosporine or the biologics instead of debridement, which makes the issue worse. […] Once a PG diagnosis is confirmed, with a combination of histopathology from a biopsy and the clinical signs recognized by the clinician, patients often begin a combination of topical and systemic therapies. Most patients need systemic immunosuppressant therapy (such as prednisone) to induce remission. Antibiotics such as tetracyclines may also be used in conjunction for their anti-inflammatory effects. […] Undiagnosed cases of pyoderma gangrenosum can be life-altering for the patient. These chronic wounds produce intense pain, odor, and discomfort. Plus, they often affect a patients emotional well-being, as wound care can be both depressing and isolating.

• #60 Pyoderma Gangrenosum Causes, Treatments, & Misdiagnosis

  https://www.epiphanydermatology.com/medical-dermatology/pyoderma-gangrenosum-treatment/

  Pyoderma gangrenosum treatment is extremely different from treating the illnesses it mimics. Typically, treating PG requires a high-dose systemic corticosteroid or immunomodulating medications such as cyclosporine or the biologics instead of debridement, which makes the issue worse. […] Once a PG diagnosis is confirmed, with a combination of histopathology from a biopsy and the clinical signs recognized by the clinician, patients often begin a combination of topical and systemic therapies. Most patients need systemic immunosuppressant therapy (such as prednisone) to induce remission. Antibiotics such as tetracyclines may also be used in conjunction for their anti-inflammatory effects. […] Undiagnosed cases of pyoderma gangrenosum can be life-altering for the patient. These chronic wounds produce intense pain, odor, and discomfort. Plus, they often affect a patients emotional well-being, as wound care can be both depressing and isolating.

• #61 Adult Pyoderma Gangrenosum | Medical Dermatology Specialists, P.C.

  https://www.atlantamedicaldermatology.com/treatments/clinical-trials/adult-pyoderma-gangrenosum/

  Medical Dermatology Specialists is committed to providing safe and effective treatments for adult pyoderma gangrenosum. This rare and challenging condition can cause severe symptoms that affect both physical and emotional well-being, requiring specialized care and support. […] If your pyoderma gangrenosum has not responded to traditional treatments, we invite you to explore our unique dermatology practice and research opportunities in Atlanta. […] We understand the physical and emotional challenges associated with pyoderma gangrenosum, as it can greatly impact mobility, daily activities, and quality of life.

• #62 Pyoderma gangrenosum | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/pyoderma-gangrenosum

  Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. Trauma to the skin may worsen existing sores or bring on new ones. […] With treatment you’re likely to recover from pyoderma gangrenosum. It may take a long time and you may feel stressed about whether new sores will form.

• #63 Pyoderma gangrenosum – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pyoderma-gangrenosum/diagnosis-treatment/drc-20350392

  Our caring team of Mayo Clinic experts can help you with your pyoderma gangrenosum-related health concerns […] Treatment of pyoderma gangrenosum is aimed at reducing swelling, controlling pain and helping skin sores heal. […] In addition to applying medicine to your wounds, a healthcare professional may cover them with a moist nonstick dressing and, perhaps, an elasticized wrap. You may be asked to keep the affected area raised. Follow instructions you receive for wound care. […] Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. […] With treatment you’re likely to recover from pyoderma gangrenosum. It may take a long time and you may feel stressed about whether new sores will form. You may find it helpful to talk with a counselor, medical social worker, or other people who have or had pyoderma gangrenosum. You may want to connect with a support group in person or online. Ask your healthcare professional for suggestions.

• #64 Pyoderma gangrenosum | Altru Health System

  https://www.altru.org/health-library/conditions/pyoderma-gangrenosum

  Treatment of pyoderma gangrenosum is aimed at reducing swelling, controlling pain and helping skin sores heal. Medicines are the most common treatment. Treatment also might involve wound care and surgery. Your treatment depends on your health, how many sores you have, how deep they are and how fast they’re growing. […] In addition to applying medicine to your wounds, a healthcare professional may cover them with a moist nonstick dressing and, perhaps, an elasticized wrap. You may be asked to keep the affected area raised. Follow instructions you receive for wound care. […] Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. Trauma to the skin may worsen existing sores or bring on new ones. […] With treatment you’re likely to recover from pyoderma gangrenosum. It may take a long time and you may feel stressed about whether new sores will form. You may find it helpful to talk with a counselor, medical social worker, or other people who have or had pyoderma gangrenosum. You may want to connect with a support group in person or online. Ask your healthcare professional for suggestions.

• #65 Pyoderma Gangrenosum – Causes, Symptoms and Treatment | Apollo Hospitals

  https://www.apollohospitals.com/diseases-and-conditions/pyoderma-gangrenosum-causes-symptoms-and-treatment/

  Pyoderma gangrenosum usually gets better with treatment. […] Pain medication: Wound care. Apart from applying medicine directly to the wounds, your wound care specialist (doctor) will cover them with a moist (not wet or dry), nonadherent dressing and, maybe, an elasticized wrap. You might be asked to keep the affected place elevated. […] If the ulcers on the skin are large and require help with healing, your physician might suggest a skin graft. […] It is helpful to speak to a counselor, medical social worker or other people who have or had pyoderma gangrenosum.

• #66 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #67 Pyoderma Gangrenosum on the Lower Extremity | Consultant360

  https://www.consultant360.com/photoclinic/pyoderma-gangrenosum-lower-extremity

  A 53-year-old woman presented for a dermatology consult for a spreading ulcer on the lateral left calf. […] Given the pertinent history and physical examination, the condition was diagnosed as pyoderma gangrenosum and was treated with 5 g topical clobetasol 0.05% ointment twice daily under nonadherent dressings. Her pain improved significantly after a single day of treatment. After 3 weeks of treatment, the lesion improved significantly. […] Treatment of pyoderma gangrenosum depends on severity. Stable or slowly growing lesions can be treated with compresses with occlusive dressing as pyoderma gangrenosum can spontaneously regress. Potent topical corticosteroids, topical dapsone, or topical tacrolimus can be considered for more persistent lesions. Rapid progression, extensive disease, or facial involvement may necessitate the use of systemic corticosteroids, cyclosporine, or infliximab. […] First-line treatments include gentle wound care and potent topical corticosteroids with a taper as the lesion improves. When in doubt, consider consulting a dermatologist.

• #68 Pyoderma Gangrenosum (PG) | OHSU

  https://www.ohsu.edu/dermatology/pyoderma-gangrenosum-pg

  Immunosuppressive medications (topical or systemic) are considered first-line treatments. These include topical corticosteroids (e.g. clobetasol), intralesional corticosteroids (e.g. triamcinolone) or systemic corticosteroids (e.g. prednisone). Other options include topical calcineurin inhibitors (e.g. tacrolimus) or cyclosporine. The presence of associated comorbidities should be considered when selecting medications for maintenance therapy such as biologics (e.g. infliximab in patients with PG and inflammatory bowel disease). Your provider will discuss what options may work best for you. […] We utilize this multidisciplinary care approach in our treatment and research of pyoderma gangrenosum (PG). […] Our dermatologists frequently work with rheumatologists due to the inflammatory nature of PG which can manifest in inflammation of the joints.

• #69 Pyoderma Gangrenosum (PG) | OHSU

  https://www.ohsu.edu/dermatology/pyoderma-gangrenosum-pg

  Immunosuppressive medications (topical or systemic) are considered first-line treatments. These include topical corticosteroids (e.g. clobetasol), intralesional corticosteroids (e.g. triamcinolone) or systemic corticosteroids (e.g. prednisone). Other options include topical calcineurin inhibitors (e.g. tacrolimus) or cyclosporine. The presence of associated comorbidities should be considered when selecting medications for maintenance therapy such as biologics (e.g. infliximab in patients with PG and inflammatory bowel disease). Your provider will discuss what options may work best for you. […] We utilize this multidisciplinary care approach in our treatment and research of pyoderma gangrenosum (PG). […] Our dermatologists frequently work with rheumatologists due to the inflammatory nature of PG which can manifest in inflammation of the joints.

• #70 Pyoderma gangrenosum – BAD Patient Hub

  https://www.skinhealthinfo.org.uk/condition/pyoderma-gangrenosum/

  Pyoderma gangrenosum is a rare treatable cause of skin ulceration. […] Pyoderma gangrenosum is often difficult to treat and may take some time to heal. More than one treatment may need to be tried. Skin grafts and surgery are not treatment options as they often fail and may cause enlargement of the ulcer. […] Treatment depends on the severity of the disease. Mild disease is treated with topical creams or ointments, including corticosteroids and calcineurin inhibitors (such as tacrolimus). More severe disease is often managed with oral or injection therapies. […] In very severe cases your doctor may consider other stronger, immunosuppressive medicines including cyclophosphamide, intravenous steroids or immunoglobulins.

• #71 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  Pyoderma gangrenosum (PG) is a reactive non-infectious inflammatory dermatosis falling under the spectrum of the neutrophilic dermatoses. Treatment of PG remains largely anecdotal, with no national or international guidelines, and is selected according to severity and rate of progression. Despite being a well-recognised condition, there is often a failure to make an early diagnosis of PG. This diagnosis should be actively considered when assessing ulcers, as prompt treatment may avoid the complications of prolonged systemic therapy, delayed wound healing and scarring. […] First-line treatment is aimed at optimising local wound care, particularly important in cases of PG arising on the leg, where wound healing can be delayed by vascular disease. Supportive therapy with appropriate dressings, compression (if arterial insufficiency has been excluded) and adequate analgesia are all essential to optimise healing. Potent topical corticosteroids and tacrolimus ointment applied to the ulcer surface are useful and intralesional injections of corticosteroid into the erythematous active border may be considered.

• #72 Pyoderma Gangrenosum (PG) | OHSU

  https://www.ohsu.edu/dermatology/pyoderma-gangrenosum-pg

  Immunosuppressive medications (topical or systemic) are considered first-line treatments. These include topical corticosteroids (e.g. clobetasol), intralesional corticosteroids (e.g. triamcinolone) or systemic corticosteroids (e.g. prednisone). Other options include topical calcineurin inhibitors (e.g. tacrolimus) or cyclosporine. The presence of associated comorbidities should be considered when selecting medications for maintenance therapy such as biologics (e.g. infliximab in patients with PG and inflammatory bowel disease). Your provider will discuss what options may work best for you. […] We utilize this multidisciplinary care approach in our treatment and research of pyoderma gangrenosum (PG). […] Our dermatologists frequently work with rheumatologists due to the inflammatory nature of PG which can manifest in inflammation of the joints.

• #73 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #74 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Systemic therapy is required in patients with all but superficial lesions. Topical agents also do not address systemic disease and as the disease progresses a combination of topical and systemic agents may be required. […] Surgery is not generally recommended due to the risk of pathergy; as a result the ulcers could potentially worsen following surgery. However, there are a few reports in the literature of success following surgical intervention. […] Pain associated with PG can be distressing for the patient. Patients report the pain as stabbing in nature. There are reports of severe pain leading to amputation of the affected limb. The source of pain associated with PG is multifactorial and is attributed to the inflammatory process in the dermis and subsequent ulceration. Pain levels should be monitored and as the ulcer improves pain levels should decrease.

• #75

  https://link.springer.com/article/10.1007/s40265-023-01931-3

  Systemic therapy with corticosteroids and/or cyclosporine remains the treatment of choice for most patients with pyoderma gangrenosum. […] Based on new data, systemic therapies with biologics are gaining importance as alternative or first-line therapy in patients with inflammatory comorbidities. […] Concomitant topical therapy can be given with classic immunosuppressants, e.g. corticosteroids or calcineurin inhibitors. […] There should always be a special focus on pain management. […] Besides medical management to control the associated comorbidity and the inflammation inherent to PG with either local pharmacologic therapy and/or systemic therapy, wound care management and pain control also needs to be addressed throughout the treatment course. […] Local corticosteroid therapies can cause skin atrophy but have a much lower rate of other significant side effects and therefore, in our opinion, may contribute to reducing systemic immunosuppression.

• #76 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  In more severe disease, systemic therapy is required. Oral corticosteroids (0.51 mg/kg/day) are the mainstay of treatment and are used to gain rapid control. Ciclosporin can be used either alone or in combination with corticosteroids as a steroid-sparing agent, in cases where prolonged treatment is required. […] Thus far infliximab has the largest body of evidence to support its early use in PG. In a RCT investigating the use of infliximab (5 mg/kg intravenous) versus placebo, 69% of patients demonstrated clinical improvement at week six after just one infusion. […] Despite being a well-recognised condition there is often a failure to make an early diagnosis of PG. It is important for all clinicians to be aware of this condition and to actively consider PG when assessing patients with ulcers, as appropriate and prompt treatment at an early stage of the disease may avoid the complications of prolonged systemic treatment, delayed wound healing and scarring.

• #77 Treatment of Pyoderma Gangrenosum | Wound Care Education

  https://woundeducators.com/pyoderma-gangrenosum-treatment/?srsltid=AfmBOorPRRW6jqcrrS5zU98yg1ovr_Jr05pTagSSwKxhCVLlSzYrHPhw

  Pyoderma gangrenosum is generally managed through a stepwise approach using a combination of systemic and topical therapies. Immunosuppression with corticosteroids and ciclosporin is the mainstay of treatment, with the use of other agents largely dependent on local protocols and experience. […] Topical treatment is essential for the management of emerging ulcers. Highly potent topical corticosteroids have been shown to induce remission in certain cases, while triamcinolone injected into the ulcer edge and topical tacrolimus have both been shown to be effective certain patients. […] Systemic therapy is particularly important in patients with widespread or rapidly progressing disease. Most patients are prescribed oral corticosteroids early in the disease to try to induce remission. […] Treatment of pyoderma gangrenosum is often based on trial and error, and long-term outcomes are unpredictable. However, if poorly managed, the condition can be severely debilitating with a devastating effect on quality of life.

• #78 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  In more severe disease, systemic therapy is required. Oral corticosteroids (0.51 mg/kg/day) are the mainstay of treatment and are used to gain rapid control. Ciclosporin can be used either alone or in combination with corticosteroids as a steroid-sparing agent, in cases where prolonged treatment is required. […] Thus far infliximab has the largest body of evidence to support its early use in PG. In a RCT investigating the use of infliximab (5 mg/kg intravenous) versus placebo, 69% of patients demonstrated clinical improvement at week six after just one infusion. […] Despite being a well-recognised condition there is often a failure to make an early diagnosis of PG. It is important for all clinicians to be aware of this condition and to actively consider PG when assessing patients with ulcers, as appropriate and prompt treatment at an early stage of the disease may avoid the complications of prolonged systemic treatment, delayed wound healing and scarring.

• #79

  https://link.springer.com/article/10.1007/s40265-023-01931-3

  Systemic therapy with corticosteroids and/or cyclosporine remains the treatment of choice for most patients with pyoderma gangrenosum. […] Based on new data, systemic therapies with biologics are gaining importance as alternative or first-line therapy in patients with inflammatory comorbidities. […] Concomitant topical therapy can be given with classic immunosuppressants, e.g. corticosteroids or calcineurin inhibitors. […] There should always be a special focus on pain management. […] Besides medical management to control the associated comorbidity and the inflammation inherent to PG with either local pharmacologic therapy and/or systemic therapy, wound care management and pain control also needs to be addressed throughout the treatment course. […] Local corticosteroid therapies can cause skin atrophy but have a much lower rate of other significant side effects and therefore, in our opinion, may contribute to reducing systemic immunosuppression.

• #80 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  In more severe disease, systemic therapy is required. Oral corticosteroids (0.51 mg/kg/day) are the mainstay of treatment and are used to gain rapid control. Ciclosporin can be used either alone or in combination with corticosteroids as a steroid-sparing agent, in cases where prolonged treatment is required. […] Thus far infliximab has the largest body of evidence to support its early use in PG. In a RCT investigating the use of infliximab (5 mg/kg intravenous) versus placebo, 69% of patients demonstrated clinical improvement at week six after just one infusion. […] Despite being a well-recognised condition there is often a failure to make an early diagnosis of PG. It is important for all clinicians to be aware of this condition and to actively consider PG when assessing patients with ulcers, as appropriate and prompt treatment at an early stage of the disease may avoid the complications of prolonged systemic treatment, delayed wound healing and scarring.

• #81 Pyoderma Gangrenosum: A Diagnostic Challenge for the Surgical Consultant | ACS

  https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v4n1/harrington-pyoderma-gangrenosum/

  Pyoderma gangrenosum (PG) is a rare, sterile, neutrophilic dermatosis occurring in 0.3-1.0 per 100,000 persons. The disease can present anywhere on the body, but most typically involve the anterior lower extremity and trunk. Wounds begin as a pustule or nodule and rapidly progress to painful ulcers. Diagnosis is made based on clinical signs, including erythema, undermined borders, multiple ulcers, and history of inflammatory bowel disease (IBD), along with biopsy characteristics, as defined in the Delphi criteria. Treatment is multimodal, involving wound care, topical therapies, and immunosuppression, and wound resolution occurs slowly, with an average of 20.37 weeks to complete healing. […] Given the frequency with which pathergy is associated with PG, wound care must avoid adherent dressings and irritating solutions. Further, any unnecessary manipulation of the ulcer bed should be avoided. Topical therapy, such as steroid application, is often a useful adjunct and inter-lesion injections such as Kenalog also facilitate healing in these complex wounds. Systemic immunosuppressive therapy with oral corticosteroids or cyclosporine is commonly employed as first-line therapy. However, tumor necrosis factor (TNF) inhibitors, including infliximab, adalimumab, and enteracept, have all been reported to demonstrate greater than 85% response rate and nearly 70% complete response rate leading some to suggest their use early in the treatment of PG.

• #82 Pyoderma Gangrenosum (PG) | OHSU

  https://www.ohsu.edu/dermatology/pyoderma-gangrenosum-pg

  Immunosuppressive medications (topical or systemic) are considered first-line treatments. These include topical corticosteroids (e.g. clobetasol), intralesional corticosteroids (e.g. triamcinolone) or systemic corticosteroids (e.g. prednisone). Other options include topical calcineurin inhibitors (e.g. tacrolimus) or cyclosporine. The presence of associated comorbidities should be considered when selecting medications for maintenance therapy such as biologics (e.g. infliximab in patients with PG and inflammatory bowel disease). Your provider will discuss what options may work best for you. […] We utilize this multidisciplinary care approach in our treatment and research of pyoderma gangrenosum (PG). […] Our dermatologists frequently work with rheumatologists due to the inflammatory nature of PG which can manifest in inflammation of the joints.

• #83 Pyoderma gangrenosum – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/pyoderma-gangrenosum/

  Pyoderma gangrenosum ulcers can develop quickly. They usually clear up with treatment, but scarring and recurrences are common. […] Treatment of pyoderma gangrenosum is aimed at reducing inflammation, controlling pain, promoting wound healing and controlling any underlying disease. Your treatment will depend on several factors, including your health and the number, size, depth and growth rate of your skin ulcers. […] In addition to applying medicine directly to your wounds, your doctor or wound care specialist will cover them with a nonadherent, moist (not wet or dry) dressing and, perhaps, an elasticized wrap. You may be asked to keep the affected area elevated. […] Follow your doctor’s instructions regarding wound care. This is especially important because many of the oral medications prescribed for pyoderma gangrenosum suppress your immune system, which increases your risk of infection.

• #84 Case study: Peristomal pyoderma gangrenosum – Wound Care Advisor

  https://woundcareadvisor.com/case-study-peristomal-pyoderma-gangrenosum/

  On April 4, 2013, Mrs. Thompson began receiving daily clobetasol propionate 0.05%, a high-dose steroid cream applied to the peristomal area. […] The treatment was re-evaluated every 14 days, as recommended by the manufacturer, because of the risk for hyperglycemia, which did not occur. […] By June 13, 2013, 72 days later, the lesions had healed and we resumed biweekly appliance changes. […] Comorbid conditions play an important role in effectively diagnosing and treating skin breakdown. […] My commitment, along with the commitment of my colleagues, resulted in our ability to find a solution for Mrs. Thompson’s condition.

• #85 Pyoderma Gangrenosum: Causes, Symptoms & Treatments

  https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg

  Pyoderma gangrenosum is a skin condition linked to certain autoimmune diseases or an earlier skin injury. […] Medications and other treatment options can relieve your symptoms. […] Early diagnosis and treatment are important in preventing scars. […] Trauma, including cuts, punctures and scrapes, can worsen your symptoms. Be careful to avoid any trauma that can cause more ulcers. […] It’s also important to keep your wounds clean to prevent infection. […] If you have a prescribed topical medication, wash your wound with clean running water and soap. Apply the medication to your wound, and then cover it with a nonadhesive bandage. […] For more severe ulcers, your healthcare provider may recommend covering them in a hydrocolloid bandage (dressing). […] Pyoderma gangrenosum is difficult to treat. Even with proper treatment, it may take weeks or even months to heal. […] If you have pyoderma gangrenosum, it’s important to discuss your diagnosis with any healthcare provider who’s considering a procedure that may damage your skin, such as surgery. […] They must consider if the procedure’s benefits outweigh the risks of triggering pyoderma gangrenosum.

• #86 Pyoderma Gangrenosum: Causes, Symptoms & Treatments

  https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg

  Pyoderma gangrenosum is a skin condition linked to certain autoimmune diseases or an earlier skin injury. […] Medications and other treatment options can relieve your symptoms. […] Early diagnosis and treatment are important in preventing scars. […] Trauma, including cuts, punctures and scrapes, can worsen your symptoms. Be careful to avoid any trauma that can cause more ulcers. […] It’s also important to keep your wounds clean to prevent infection. […] If you have a prescribed topical medication, wash your wound with clean running water and soap. Apply the medication to your wound, and then cover it with a nonadhesive bandage. […] For more severe ulcers, your healthcare provider may recommend covering them in a hydrocolloid bandage (dressing). […] Pyoderma gangrenosum is difficult to treat. Even with proper treatment, it may take weeks or even months to heal. […] If you have pyoderma gangrenosum, it’s important to discuss your diagnosis with any healthcare provider who’s considering a procedure that may damage your skin, such as surgery. […] They must consider if the procedure’s benefits outweigh the risks of triggering pyoderma gangrenosum.

• #87 Case study: Peristomal pyoderma gangrenosum – Wound Care Advisor

  https://woundcareadvisor.com/case-study-peristomal-pyoderma-gangrenosum/

  Mrs. Thompson, a 77-year-old resident in a long-term care facility, had diabetes, peripheral vascular disease, and a history of a cerebrovascular accident, which left her with left-sided paralysis. […] The diagnosis of peristomal PG is based on the patient’s history and characteristics of skin breakdown because biopsies and cultures can’t confirm the diagnosis. […] The unknown etiology of the peristomal lesions makes treatment decisions challenging. […] When lesions are mild and there is absence of systemic disease, it may be possible to control the condition with topical corticosteroids and dressings. […] Based on what we could find in the literature and discussion with the geriatric nurse practitioner and Mrs. Thompson’s primary care physician, we decided to start her on high-dose steroid cream.

• #88

  https://link.springer.com/article/10.2165/11595240-000000000-00000

  Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful, necrotic ulceration. […] Successful management of PG typically requires multiple modalities to reduce inflammation and optimize wound healing, in addition to treatment of any underlying diseases. […] Prednisone and cyclosporine have been mainstays of systemic treatment for PG, although increasing evidence supports the use of biologic therapies, such as tumor necrosis factor-a inhibitors, for refractory cases of PG. […] Here, we review the clinical presentation and pathophysiology of PG, as well as its associated conditions, diagnostic work-up, and management. […] Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.

• #89

  https://journals.lww.com/jwocnonline/fulltext/1995/09000/caring_for_the_patient_with_peristomal_pyoderma.11.aspx

  Pyoderma gangrenosum Is an ulcerating skin condition associated with Inflammatory bowel disease and other diseases. During an 18-month period beginning In the fall of 1991, seven patients were followed up for pyoderma gangrenosum. Three of these cases, with assessment and treatment plans, are presented. A discussion of treatment principles for managing pyoderma gangrenosum follows.

• #90 Case study: Peristomal pyoderma gangrenosum – Wound Care Advisor

  https://woundcareadvisor.com/case-study-peristomal-pyoderma-gangrenosum/

  On April 4, 2013, Mrs. Thompson began receiving daily clobetasol propionate 0.05%, a high-dose steroid cream applied to the peristomal area. […] The treatment was re-evaluated every 14 days, as recommended by the manufacturer, because of the risk for hyperglycemia, which did not occur. […] By June 13, 2013, 72 days later, the lesions had healed and we resumed biweekly appliance changes. […] Comorbid conditions play an important role in effectively diagnosing and treating skin breakdown. […] My commitment, along with the commitment of my colleagues, resulted in our ability to find a solution for Mrs. Thompson’s condition.

• #91 Pyoderma Gangrenosum: A Diagnostic Challenge for the Surgical Consultant | ACS

  https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v4n1/harrington-pyoderma-gangrenosum/

  Surgeons will often be involved in the care of patients with PG. Peristomal location is a common site for PG wounds in IBD patients requiring operative management, and pathergy also allows PG to occur in traumatic wounds. Further, as pyoderma wounds present with erythema, purulence, and pain, they can mimic abscesses in their earliest phases. Patients often undergo serial treatment with antibiotics or incision and drainage procedures before obtaining the appropriate diagnosis.

• #92

  https://link.springer.com/article/10.2165/11595240-000000000-00000

  Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful, necrotic ulceration. […] Successful management of PG typically requires multiple modalities to reduce inflammation and optimize wound healing, in addition to treatment of any underlying diseases. […] Prednisone and cyclosporine have been mainstays of systemic treatment for PG, although increasing evidence supports the use of biologic therapies, such as tumor necrosis factor-a inhibitors, for refractory cases of PG. […] Here, we review the clinical presentation and pathophysiology of PG, as well as its associated conditions, diagnostic work-up, and management. […] Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.

• #93 Pyoderma Gangrenosum–Like Lesion in an Older Adult

  https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.117/html?srsltid=AfmBOoo5E7y3sdbkLoM7qzV6cW8o8fEXXK5eTFniTLPCoAEqeQ10ONZU

  Pyoderma gangrenosum (PG) is a rare but serious neutrophilic dermatosis characterized by ulcerative lesions with violaceous borders. […] This case provides insights into the challenges that arise in the diagnosis and management of PG in an older patient with extensive comorbidities. […] It also highlights the importance of considering PG as a diagnosis for older patients with a distinctive inflammatory ulcer that does not respond to antibiotics and topical wound care, since timely treatment with low-dose steroids can lead to quick healing by aborting the underlying autoinflammatory process. […] Older adults are a challenging treatment population because it is often necessary to manage comorbid conditions while avoiding polypharmacy. […] Current PG management guidelines have not differentiated between old and young patients, but steroid use in older adults requires caution because of adverse effects.

• #94 Pyoderma Gangrenosum–Like Lesion in an Older Adult

  https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.117/html?srsltid=AfmBOoo5E7y3sdbkLoM7qzV6cW8o8fEXXK5eTFniTLPCoAEqeQ10ONZU

  It is not clear whether attenuated steroid doses can be as effective as high-dose therapy for older patients with PG, although physicians may be concerned that low-dose treatment would not induce full remission. […] This case illustrates unique aspects of PG diagnosis and management in an older adult with cognitive and physical impairments. […] Our case further showed that relatively low-dose prednisone therapy can be effective. […] Prednisone doses greater than 60 mg/d are often used as first-line PG treatment, but the current case illustrates that a lower dose can be sufficient to promote rapid resolution while avoiding adverse treatment effects. […] To improve PG outcomes in older patients, manual therapy could also be used to facilitate healing, particularly among patients with lower extremity lesions and venous insufficiency.

• #95 Pyoderma Gangrenosum–Like Lesion in an Older Adult

  https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.117/html?srsltid=AfmBOoo5E7y3sdbkLoM7qzV6cW8o8fEXXK5eTFniTLPCoAEqeQ10ONZU

  We adopted a practical strategy with treatment response as a diagnostic indicator following empiric steroid treatment for presumptive PG. […] This case report emphasizes the importance of considering PG as an early possible diagnosis in older adult patients presenting with nonhealing skin ulcers refractory to antibiotic therapy and wound care. In such patients, short-term, low-dose prednisone (15 mg/d or 0.3 mg/kg/d for 7 days) can be effective for the management of PG.

• #96 Pyoderma Gangrenosum–Like Lesion in an Older Adult

  https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.117/html?srsltid=AfmBOoo5E7y3sdbkLoM7qzV6cW8o8fEXXK5eTFniTLPCoAEqeQ10ONZU

  Pyoderma gangrenosum (PG) is a rare but serious neutrophilic dermatosis characterized by ulcerative lesions with violaceous borders. […] This case provides insights into the challenges that arise in the diagnosis and management of PG in an older patient with extensive comorbidities. […] It also highlights the importance of considering PG as a diagnosis for older patients with a distinctive inflammatory ulcer that does not respond to antibiotics and topical wound care, since timely treatment with low-dose steroids can lead to quick healing by aborting the underlying autoinflammatory process. […] Older adults are a challenging treatment population because it is often necessary to manage comorbid conditions while avoiding polypharmacy. […] Current PG management guidelines have not differentiated between old and young patients, but steroid use in older adults requires caution because of adverse effects.

• #97 Pyoderma Gangrenosum–Like Lesion in an Older Adult

  https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.117/html?srsltid=AfmBOoo5E7y3sdbkLoM7qzV6cW8o8fEXXK5eTFniTLPCoAEqeQ10ONZU

  It is not clear whether attenuated steroid doses can be as effective as high-dose therapy for older patients with PG, although physicians may be concerned that low-dose treatment would not induce full remission. […] This case illustrates unique aspects of PG diagnosis and management in an older adult with cognitive and physical impairments. […] Our case further showed that relatively low-dose prednisone therapy can be effective. […] Prednisone doses greater than 60 mg/d are often used as first-line PG treatment, but the current case illustrates that a lower dose can be sufficient to promote rapid resolution while avoiding adverse treatment effects. […] To improve PG outcomes in older patients, manual therapy could also be used to facilitate healing, particularly among patients with lower extremity lesions and venous insufficiency.

• #98 Pyoderma Gangrenosum–Like Lesion in an Older Adult

  https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.117/html?srsltid=AfmBOoo5E7y3sdbkLoM7qzV6cW8o8fEXXK5eTFniTLPCoAEqeQ10ONZU

  It is not clear whether attenuated steroid doses can be as effective as high-dose therapy for older patients with PG, although physicians may be concerned that low-dose treatment would not induce full remission. […] This case illustrates unique aspects of PG diagnosis and management in an older adult with cognitive and physical impairments. […] Our case further showed that relatively low-dose prednisone therapy can be effective. […] Prednisone doses greater than 60 mg/d are often used as first-line PG treatment, but the current case illustrates that a lower dose can be sufficient to promote rapid resolution while avoiding adverse treatment effects. […] To improve PG outcomes in older patients, manual therapy could also be used to facilitate healing, particularly among patients with lower extremity lesions and venous insufficiency.

• #99 Pyoderma gangrenosum: a review of the clinical, mechanistic and therapeutic landscape :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-30-number-1/pyoderma-gangrenosum-review-clinical-mechanistic-and-therapeutic-landscape

  Pyoderma gangrenosum (PG) is a neutrophilic dermatosis that is uncommon and can sometimes be associated with systemic diseases. […] Current management involves optimal wound care and topical or systemic steroids or steroid sparing agents. Certain biological agents, including IL23 and IL17 antagonists, as well as JAK-STAT inhibitors, however, may hold promise in the rapid treatment of this condition. […] A combination of local and systemic treatments, along with regular wound care, has been found to confer the highest likelihood of adequate ulcer healing. […] The main goals are to protect the ulcers from experiencing further physical trauma and fostering a microenvironment that enables wound healing. […] Active ulcers will usually produce large amounts of exudate due to high neutrophil activity, which leaves the surrounding normal skin at risk of maceration and infection.

• #100

  https://link.springer.com/article/10.1007/s40265-023-01931-3

  Systemic therapy with corticosteroids and/or cyclosporine remains the treatment of choice for most patients with pyoderma gangrenosum. […] Based on new data, systemic therapies with biologics are gaining importance as alternative or first-line therapy in patients with inflammatory comorbidities. […] Concomitant topical therapy can be given with classic immunosuppressants, e.g. corticosteroids or calcineurin inhibitors. […] There should always be a special focus on pain management. […] Besides medical management to control the associated comorbidity and the inflammation inherent to PG with either local pharmacologic therapy and/or systemic therapy, wound care management and pain control also needs to be addressed throughout the treatment course. […] Local corticosteroid therapies can cause skin atrophy but have a much lower rate of other significant side effects and therefore, in our opinion, may contribute to reducing systemic immunosuppression.

• #101 Pyoderma gangrenosum is a necrotizing skin condition.

  https://woundeducators.com/pyoderma-gangrenosum/?srsltid=AfmBOoqi68GVQ-HOVAKIUyrrByzc_zIcJyHV4BmTxAOJgrNN0edsFrVd

  Pyoderma is a noninfectious, progressive necrotizing skin condition. […] Immunosuppressive and anti-infective agents are commonly prescribed. Corticosteroids are used to control inflammation. Local wound care includes gentle and limited debridement of slough and necrotic tissue. Extensive sharp or surgical debridement is contraindicated, because it increases the inflammatory response leading to severe exacerbations. Topical antimicrobials are indicated for sensitive bacterial infections. Gauze or moisture-retentive dressings should absorb wound exudate and protect the surrounding tissue. Extremity wounds may benefit from elevation and gradient compression. Negative-pressure therapy and hyperbaric oxygen have been used with some success. Wounds that have stabilized with medication have been treated successfully with skin grafting. Wound healing is extremely slow. Because recurrence is common, physicians generally continue pharmacological management for 6 to 12 months after wound closure.

• #102

  https://www.nursingcenter.com/journalarticle?Article_ID=4892175&Journal_ID=54015&Issue_ID=4892085

  ABSTRACT: Pyoderma gangrenosum (PG) is a rare disease that presents as painful ulcerations with inflammation and undermining at the borders. The ulcers can occur anywhere on the body but are most commonly seen on the lower extremities. The etiology of PG is unknown, and there are no definitive diagnostic criteria; PG is a diagnosis of exclusion, which can present serious delays in treatment. […] Patients should be treated with an interdisciplinary approach with aggressive immunosuppression, treatment of any comorbidities, maximization of nutrition status, reconstructive surgery for treatment of the wound, and physical therapy for deconditioning. […] This article presents a case study of one patient treated with a porcine urinary bladder matrix and negative-pressure wound therapy; this treatment combination provided pain relief, coverage of the wound, an acceptable aesthetic outcome, and long-term stability.

• #103 Pyoderma gangrenosum is a necrotizing skin condition.

  https://woundeducators.com/pyoderma-gangrenosum/?srsltid=AfmBOoqi68GVQ-HOVAKIUyrrByzc_zIcJyHV4BmTxAOJgrNN0edsFrVd

  Pyoderma is a noninfectious, progressive necrotizing skin condition. […] Immunosuppressive and anti-infective agents are commonly prescribed. Corticosteroids are used to control inflammation. Local wound care includes gentle and limited debridement of slough and necrotic tissue. Extensive sharp or surgical debridement is contraindicated, because it increases the inflammatory response leading to severe exacerbations. Topical antimicrobials are indicated for sensitive bacterial infections. Gauze or moisture-retentive dressings should absorb wound exudate and protect the surrounding tissue. Extremity wounds may benefit from elevation and gradient compression. Negative-pressure therapy and hyperbaric oxygen have been used with some success. Wounds that have stabilized with medication have been treated successfully with skin grafting. Wound healing is extremely slow. Because recurrence is common, physicians generally continue pharmacological management for 6 to 12 months after wound closure.

• #104 Pyoderma gangrenosum | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/pyoderma-gangrenosum?content_id=CON-20154762

  Pyoderma gangrenosum can cause painful, open sores that have blue or purple edges. […] Treatment of pyoderma gangrenosum is aimed at reducing swelling, controlling pain and helping skin sores heal. […] Medicines are the most common treatment. Treatment also might involve wound care and surgery. […] In addition to applying medicine to your wounds, a healthcare professional may cover them with a moist nonstick dressing and, perhaps, an elasticized wrap. […] Follow instructions you receive for wound care. […] Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. […] If sores are large and aren’t healing, a skin graft may be an option. […] With treatment you’re likely to recover from pyoderma gangrenosum. […] You may find it helpful to talk with a counselor, medical social worker, or other people who have or had pyoderma gangrenosum.

• #105

  https://link.springer.com/article/10.1007/s40265-023-01931-3

  When PG occurs on the lower legs, compression bandages should be applied to support anti-inflammatory activity by reducing oedema. […] Pain remains an important aspect to take into consideration when addressing the severity of PG. […] The addition of systemic treatment should be considered if progress is lacking after 24 weeks of therapy. […] In general, topical therapy for PG is used as an adjuvant to systemic therapy and is usually applied to the ulcer itself and/or ulcer edges. […] It is always difficult to determine when systemic therapy should be stopped. […] With control of the inflammation, the pain should decrease and the livid border around the wound should recede. […] In the future, we need to deepen our understanding of the pathophysiology of this disease, search for specific markers to aid in the enrolment of patients in clinical studies and possibly to distinguish PG from other ulcerative skin diseases, and ultimately develop targeted therapies that can feasible be studied in RCTs.

• #106 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  At each presentation the lesions should have a comprehensive assessment of the wound bed and the wound border, paying attention in particular to the type of tissue at the wound bed, amount and type of exudate, evidence of violaceous wound margins and the level of pain the patient is experiencing. The wound(s) should be measured, including length, width, depth, and, if possible, clinical photography of the wound as this allows for accurate ongoing wound assessment. The TIME principle should be used as a guide for selecting the appropriate wound dressing. Dressing selection will depend on the wound assessment; however, the dressing should be non-adherent to the wound bed and removed easily to minimise pain and trauma. […] For small lesions, such as superficial pustules or shallow ulcers, treatment can include local application of high-potency corticosteroid lotion, ointment, cream or intralesional injections. Topical agents can also be used in conjunction with systemic therapy for patients with severe PG.

• #107 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Pyoderma gangrenosum (PG) is a rare neutrophilic ulcerative dermatosis that poses a high burden of morbidity due to underdiagnosis, resistance to therapy, and limited therapeutic options. […] Optimization of wound care strategies and multimodal anti-inflammatory approaches are necessary to mitigate multiple converging pathways of inflammation leading to delayed healing, which is further complicated by additional factors such as pathergy. […] Wound management includes gentle cleansing without sharp debridement, limited topical antibacterial use, and maintenance of a moist environment to promote epithelial migration. […] Dressings should aim to target the specific PG wound type, depending on the depth and exudative nature of the wound, as well as local secondary factors. […] The importance of compression therapy to decrease edema and overgranulation fits within this treatment paradigm.

• #108 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Once inflammation is maintained by local or systemic suppressive therapies, the importance of site-specific wound care is of highest consideration. […] Gentle mechanical debridement, considering risk of pathergy, an exaggerated skin injury occurring after minor trauma, and inhibition of critical colonization are essential throughout the phases of wound healing. […] Topical antibacterial use in cases of critical colonization and maintenance of an appropriately moist environment are necessary to promote epithelial migration with any acute or chronic cutaneous ulceration. […] The tissue debridement, control of infection/inflammation, moisture balance, and edge effect (TIME) principle, a guide for local wound care: the TIME. […] Overall, dressings should be nonadherent to the wound bed and removed easily to minimize trauma and subsequent pain, as well as pathergy.

• #109 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Once inflammation is maintained by local or systemic suppressive therapies, the importance of site-specific wound care is of highest consideration. […] Gentle mechanical debridement, considering risk of pathergy, an exaggerated skin injury occurring after minor trauma, and inhibition of critical colonization are essential throughout the phases of wound healing. […] Topical antibacterial use in cases of critical colonization and maintenance of an appropriately moist environment are necessary to promote epithelial migration with any acute or chronic cutaneous ulceration. […] The tissue debridement, control of infection/inflammation, moisture balance, and edge effect (TIME) principle, a guide for local wound care: the TIME. […] Overall, dressings should be nonadherent to the wound bed and removed easily to minimize trauma and subsequent pain, as well as pathergy.

• #110 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Wound management and topical care are important, but a systemic antiinflammatory / immunosuppressive drug is the main focus of PG management. […] Topical wound care requires experienced health professionals. Treatments must reduce pain and avoid superinfection. It is also important to minimize any physical trauma, including physical wound debridement, as pathergy is a cause of initiation or aggravation of PG lesions. […] Antiseptic solutions must be used for cleansing. Nonadhesive dressings should be applied over the lesions and held in place with elasticized bandages. Hydrocolloid dressings are useful. […] Systemic antiimmflamatory/immunosuppressive therapy should be intiated promptly after diagnosis confirmation. As mentioned in treatment options, corticosteroids are the treatment of choice for inital therapy to suppress the inflammatory process. After an initial suppression period of at least 6 weeks (depending on the size and number of lesions), a steroid-sparing agent is typically added and steroid/steroid-sparing therapies are consolidated so that corticosteroids can be weaned and the patient can be maintained on a steroid-sparing agent.

• #111 A Wound Care Specialist’s Approach to Pyoderma Gangrenosum

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7698649/

  Compression therapy first reduces inflammation and fluid accumulation, which would otherwise impede wound healing. […] Compression therapy has been found to be an effective treatment for PG without major adverse effects. […] A multimodal approach to effective PG treatment has been demonstrated in the literature. […] The wound care process in PG always involves gentle cleansing, topical antibacterial use in cases of suspected colonization or infection, as well as maintenance of appropriate fluid balance. […] Numerous dressings can be used to target the specific wound type in PG, including superficial wounds, eschar, exudative wounds, granulating wounds, and colonized wounds.

• #112 Causes, Symptoms & Treatment of Pyoderma Gangrenosum

  https://legsmatter.org/information-and-support/skin-concerns/pyoderma-gangrenosum/

  Pyoderma Gangrenosum is often difficult to treat and may take some time to heal, especially if the lesions are on the lower leg. Treatment requires the following important interventions. […] Management of pain is essential this condition can be extremely painful and the patient will need strong analgesia initially often suggested by the Dermatologist. It is important to have treatment for neuropathic pain and anti-neuropathic medication will be required if compression is to be tolerated. Pain will reduce if the inflammatory condition is under control with the medication. […] Compression is an essential part of the treatment if you have PG on your legs or feet and this important fact is often missed. Medical management may not be enough on its own to control this condition or any associated swelling. Even if the leg is not very swollen the compression bandage or sock will reduce the level of exudate and make the wounds less wet. You may want to start with mild compression, but increase the level of compression as soon as you can so the limb can benefit from the anti-inflammatory properties of the compression therapy.

• #113 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Systemic therapy is required in patients with all but superficial lesions. Topical agents also do not address systemic disease and as the disease progresses a combination of topical and systemic agents may be required. […] Surgery is not generally recommended due to the risk of pathergy; as a result the ulcers could potentially worsen following surgery. However, there are a few reports in the literature of success following surgical intervention. […] Pain associated with PG can be distressing for the patient. Patients report the pain as stabbing in nature. There are reports of severe pain leading to amputation of the affected limb. The source of pain associated with PG is multifactorial and is attributed to the inflammatory process in the dermis and subsequent ulceration. Pain levels should be monitored and as the ulcer improves pain levels should decrease.

• #114 Pyoderma Gangrenosum Treatment: Top Management Strategies | Maggie Yu MD, IFMCP

  https://drmaggieyu.com/blog/pyoderma-gangrenosum-treatment-top-management-strategies/

  Pyoderma gangrenosum is a rare but serious neutrophilic dermatosis that can be tough to manage. […] Comprehensive wound care, including proper cleaning and dressing, significantly aids in healing and therapy for classic pyoderma. […] Specialized wound care is vital in managing pyoderma gangrenosum. This includes regular cleaning, applying appropriate dressings, and monitoring for infections. […] Pain management is necessary for patients with pyoderma gangrenosum. Dressing changes can be particularly painful. Doctors often recommend pain relief medications before changing dressings. […] Regular monitoring of the wound is essential. Doctors need to check for signs of infection or other complications. Patients may need frequent visits to their healthcare provider to ensure proper healing.

• #115 The challenges of managing patients with pyoderma gangrenosum: three case reports :: Cambridge Media Journals

  https://journals.cambridgemedia.com.au/wpr/volume-24-no-1/challenges-managing-patients-pyoderma-gangrenosum-three-case-reports

  Pyoderma gangrenosum (PG), although first described nearly 100 years ago, remains challenging for clinicians. The aim of this paper is to provide an overview of the challenges faced by the clinician in diagnosing and managing patients with PG. […] There is a paucity of guidelines for the treatment of PG. This is due to a lack of clinical controlled trials. The disease process in poorly understood and treatment is based predominately on clinical experience. Approach to treatment should be multidisciplinary, including dermatology, rheumatology, wound care specialists, pain specialists and pathologists. Treatment aim is to reduce the inflammation, minimise pain, promote wound healing, and control underlying disorders. If the patient has any underlying systemic disease, control of this often results in the control of skin lesions.

• #116 Pyoderma gangrenosum – Care at Mayo Clinic – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pyoderma-gangrenosum/care-at-mayo-clinic/mac-20350395

  Pyoderma gangrenosum care at Mayo Clinic […] Proper diagnosis and treatment are key to recovery. Your Mayo Clinic doctors work with you to develop a comprehensive treatment plan that meets your needs and considers the possible side effects of each treatment option. Your care team follows up with you to see how well the treatment is working. […] You may need treatment for other conditions related to pyoderma gangrenosum, such as chronic pain. Your Mayo Clinic dermatologists can work with other Mayo Clinic specialists and your local healthcare professional to ensure you get the care you need.

• #117 Pyoderma Gangrenosum: Causes, Symptoms & Treatments

  https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg

  Pyoderma gangrenosum is a skin condition linked to certain autoimmune diseases or an earlier skin injury. […] Medications and other treatment options can relieve your symptoms. […] Early diagnosis and treatment are important in preventing scars. […] Trauma, including cuts, punctures and scrapes, can worsen your symptoms. Be careful to avoid any trauma that can cause more ulcers. […] It’s also important to keep your wounds clean to prevent infection. […] If you have a prescribed topical medication, wash your wound with clean running water and soap. Apply the medication to your wound, and then cover it with a nonadhesive bandage. […] For more severe ulcers, your healthcare provider may recommend covering them in a hydrocolloid bandage (dressing). […] Pyoderma gangrenosum is difficult to treat. Even with proper treatment, it may take weeks or even months to heal. […] If you have pyoderma gangrenosum, it’s important to discuss your diagnosis with any healthcare provider who’s considering a procedure that may damage your skin, such as surgery. […] They must consider if the procedure’s benefits outweigh the risks of triggering pyoderma gangrenosum.

• #118 Pyoderma Gangrenosum – Dermatology Advisor

  https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/pyoderma-gangrenosum/

  Patients with PG must be managed by dermatologists with experience treating internal medicine patients, or in cooperation with an internist. Patients must be informed of the expected healing time of the ulcers, the importance of topical care, and the careful monitoring of the efficacy and side effects of the drugs used. […] Nurses and other health professionals must work in close contact with the physicians. It is important to emphasize to the patient the fact that the ulcerations, even the most dramatic ones, will heal, usually only leaving a slightly atrophic, depressed scar. In patients with recurrent PG, maintenance therapy with low-dose steroids and/or immunosuppressives will help prevent new lesions.

• #119 Pyoderma gangrenosum – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/pyoderma-gangrenosum/diagnosis-treatment/drc-20350392

  Our caring team of Mayo Clinic experts can help you with your pyoderma gangrenosum-related health concerns […] Treatment of pyoderma gangrenosum is aimed at reducing swelling, controlling pain and helping skin sores heal. […] In addition to applying medicine to your wounds, a healthcare professional may cover them with a moist nonstick dressing and, perhaps, an elasticized wrap. You may be asked to keep the affected area raised. Follow instructions you receive for wound care. […] Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. […] With treatment you’re likely to recover from pyoderma gangrenosum. It may take a long time and you may feel stressed about whether new sores will form. You may find it helpful to talk with a counselor, medical social worker, or other people who have or had pyoderma gangrenosum. You may want to connect with a support group in person or online. Ask your healthcare professional for suggestions.

• #120 Pyoderma gangrenosum | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/pyoderma-gangrenosum?content_id=CON-20154762

  Pyoderma gangrenosum can cause painful, open sores that have blue or purple edges. […] Treatment of pyoderma gangrenosum is aimed at reducing swelling, controlling pain and helping skin sores heal. […] Medicines are the most common treatment. Treatment also might involve wound care and surgery. […] In addition to applying medicine to your wounds, a healthcare professional may cover them with a moist nonstick dressing and, perhaps, an elasticized wrap. […] Follow instructions you receive for wound care. […] Because pyoderma gangrenosum can be made worse by cuts to the skin, surgery to remove dead tissue is not usually considered a good treatment option. […] If sores are large and aren’t healing, a skin graft may be an option. […] With treatment you’re likely to recover from pyoderma gangrenosum. […] You may find it helpful to talk with a counselor, medical social worker, or other people who have or had pyoderma gangrenosum.

• #121 Pyoderma Gangrenosum Causes, Treatments, & Misdiagnosis

  https://www.epiphanydermatology.com/medical-dermatology/pyoderma-gangrenosum-treatment/

  However, a correct diagnosis can drastically reduce the physical, psychological, and social effects of PG. Once treatment is initiated, PG ulcers can begin to heal in days, especially decreasing the pain, and the lesions may shrink over weeks to months, leaving a star-like scar. […] It may, unfortunately, return in the same and other sites with the flare of a systemic disorder or trauma. While misdiagnosis can be devastating, an accurate diagnosis and treatment of pyoderma gangrenosum plan can help patients resume a normal life. […] If you or someone you care about has a non-healing wound, talk to a dermatologist about the options and the possibility of pyoderma gangrenosum. The sooner a proper diagnosis is reached, the better and more quickly healing can occur.

• #122 Pyoderma gangrenosum – a guide to diagnosis and management 

  https://pmc.ncbi.nlm.nih.gov/articles/PMC6542232/

  In more severe disease, systemic therapy is required. Oral corticosteroids (0.51 mg/kg/day) are the mainstay of treatment and are used to gain rapid control. Ciclosporin can be used either alone or in combination with corticosteroids as a steroid-sparing agent, in cases where prolonged treatment is required. […] Thus far infliximab has the largest body of evidence to support its early use in PG. In a RCT investigating the use of infliximab (5 mg/kg intravenous) versus placebo, 69% of patients demonstrated clinical improvement at week six after just one infusion. […] Despite being a well-recognised condition there is often a failure to make an early diagnosis of PG. It is important for all clinicians to be aware of this condition and to actively consider PG when assessing patients with ulcers, as appropriate and prompt treatment at an early stage of the disease may avoid the complications of prolonged systemic treatment, delayed wound healing and scarring.

Zobacz więcej